Safety Considerations and Who Should Discuss This With Their Provider GLP-1 medications are not appropriate for everyone and carry specific risks including pancreatitis, thyroid safety concerns, and gastrointestinal side effects that could complicate joint mobility or medication adherence
Fatigue during GLP-1 therapy can have several causes
Side effects feel too strong Trial protocols allowed staying at the current dose for an extra 2-4 weeks when GI side effects were significant
Se nota en el apetito desde la primera semana, pero la prdida de peso y los cambios en glucosa suelen aparecer a partir de la 4 semana
Key details Compounded GLP-1s Semaglutide injections Semaglutide microdose Semaglutide oral tablets Semaglutide oral drops Tirzepatide (any form) Branded GLP-1s Ozempic Mounjaro Wegovy Zepbound Victoza Saxenda Rybelsus Other medications: Metformin, compounded liraglutide
For protocols where the inflammatory dimension is part of the research design: KPV the -MSH-derived anti-inflammatory tripeptide with documented effects on NF-B pathway activity and pro-inflammatory cytokine biology